The glioblastoma market is estimated to be valued at USD 1.30 Bn in 2025 and is expected to reach USD 3.12 Bn by 2032, growing at a compound annual growth rate (CAGR) of 13.3% from 2025 to 2032. https://timessquarereporter.com/health/glioblastoma-market-is-anticipated-to-witness-high-growth-owing-to-immunotherapy-innovations